CRINETICS PHARMACEUTICALS IN

CRNXNASDAQ

🏆 #895 by market capEarnings Nov 5US Equity

$84.96▲ $0.10 (+0.12%)

🌅 Pre-market$84.98▲ 0.02%Regular close · extended-hours price shown

🔔

Track CRNX

Get earnings, price moves & breaking news on Telegram

Track

24h▲ 0.1%

7d—

14d—

30d—

ytd▲ 82.5%

1y▲ 98.3%

🏦Market Cap

$9.01B

Small Cap

📈Revenue Growth (YoY)

2928.4%

High Growth

📊Gross Margin

—

💵FCF Margin

—

⚖️P/S Ratio

213.8x

Expensive

Otter Score

—

Insufficient data

Earnings

Q3 · 2026Reported 2026-08-03

Earnings Per Share

Actual

-1.14

Expected

-1.18

beat

+3.40%

YoY +7.30%

Revenue

Actual

$25.12M

Expected

$14.84M

beat

+69.20%

YoY +2336.30%

Consensus estimates

Recent quarters

Q3 2026

-1.14

beat

Q2 2026

-1.23

miss

Q1 2026

-1.29

beat

Q4 2025

-1.38

miss